1. Home
  2. ABCL vs LUNR Comparison

ABCL vs LUNR Comparison

Compare ABCL & LUNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$11.22

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Logo Intuitive Machines Inc.

LUNR

Intuitive Machines Inc.

HOLD

Current Price

$14.77

Market Cap

2.9B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABCL
LUNR
Founded
2012
2013
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
2.9B
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
ABCL
LUNR
Price
$11.22
$14.77
Analyst Decision
Strong Buy
Buy
Analyst Count
5
10
Target Price
$8.40
$22.35
AVG Volume (30 Days)
9.1M
9.4M
Earning Date
05-11-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
10.91
84.23
EPS
N/A
N/A
Revenue
$75,128,000.00
$210,059,000.00
Revenue This Year
N/A
$343.00
Revenue Next Year
$21.85
$16.81
P/E Ratio
N/A
N/A
Revenue Growth
160.56
N/A
52 Week Low
$2.75
$7.78
52 Week High
$12.58
$46.75

Technical Indicators

Market Signals
Indicator
ABCL
LUNR
Relative Strength Index (RSI) 60.19 40.18
Support Level $10.44 $10.72
Resistance Level N/A $20.16
Average True Range (ATR) 0.78 1.18
MACD -0.08 -0.24
Stochastic Oscillator 42.16 8.18

Price Performance

Historical Comparison
ABCL
LUNR

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

About LUNR Intuitive Machines Inc.

Intuitive Machines Inc is a space infrastructure and services company focused on enabling sustained human activity beyond Earth. It designs, builds, integrates, and operates space systems, offering infrastructure-as-a-service across low Earth orbit, geostationary orbit, cislunar space, and deep space. Its capabilities include spacecraft development and space-based network connectivity, serving commercial, civil, and national security customers. The company conducts sales both directly and through an extensive customer and partner network spanning North America, South America, Europe, Asia, and Australia, including rideshare delivery providers, lunar surface mobility providers, payload providers, communication satellite providers, and ground segment providers.

Share on Social Networks: